Clinical trial
SHIFT: Studying HIV Immunology After Fecal Transplant
NCT03163784 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SHIFT: Studying HIV Immunology After Fecal Transplant
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- June 30, 2018
- Completion date
- June 30, 2022
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
dysbiosis, hiv/aids, inflammation